VMS

Talk to a representative to learn how VMS+ can be used to help patients who have developed acute heart conditions. Learn how VMS+ aids in diagnosis and treatment by providing more accurate volumes and ejection fractions.  

HOW CAN VMS+ HELP?

 

THERE ARE MANY BENEFITS

CARDIAC QUANTIFICATION

Obtain a 3D model of the heart  and accurate, reproducible volume and ejection fraction quantification.  Generate measurements that are equivalent to MRI in less than 5 minutes. Thus, allowing the clinician to monitor a patient’s heart  more closely and provide early treatment during a viral pandemic when MRI is not readily available. 

POINT OF CARE 

 

The VMS+ system can be easily connected to any  2D cardiac ultrasound and be used in the ICU, emergency room and long term care homes. Moreover, the system can be easily disinfected with cleaning agents commonly used  by hospitals and thus aiding in infection control. 

TELEMEDICINE

 

The VMS+ software can be installed on any  personal workstation and cardiac quantification can be done remotely at any time following an echo.  Also, a clinician can easily share the 3D model of the  patient's heart and the corresponding cardiac quantification with any physician via PACS. 

INTUITIVE INTERFACE

 

Driven by a step-by-step guided workflow that enables clinicians to perform acquisition and analysis with minimal training.

Scientific Journal Review

Global evaluation of echocardiography in patients with COVID-19

European Heart Journal - Cardiovascular Imaging, jeaa178, https://doi.org/10.1093/ehjci/jeaa178, Published: 18 June 2020

Aims to describe the cardiac abnormalities in patients with COVID-19 and identify the characteristics of patients who would benefit most from echocardiography.

 

 

 

Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases,JAMA Cardiol. Published online July 27, 2020. doi:10.1001/jamacardio.2020.3551

Stay safe and healthy!

2 Sheppard Avenue East, Suite 605

Toronto Ontario M2N 5Y7

Canada

+1-416-848-4156

© 2020 Ventripoint Diagnostics Ltd. All Rights Reserved.

  • Twitter
  • LinkedIn
  • YouTube